Geode Capital Management
NMTR

Geode Capital Management’s 9 Meters Biopharma NMTR Stock Holding History

Geode Capital Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-108,821
Closed -$73.1K – 4871
2023
Q2 		$73.1K Sell
108,821
-3
-0% -$3 ﹤0.01% 4427
2023
Q1 		$151K Sell
108,824
-1
-0% -$2 ﹤0.01% 4171
2022
Q4 		$137K Sell
108,825
-6,810
-6% -$15.5K ﹤0.01% 4277
2022
Q3 		$497K Hold
115,635
– – ﹤0.01% 3731
2022
Q2 		$603K Sell
115,635
-74,655
-39% -$703K ﹤0.01% 3658
2022
Q1 		$2.28M Sell
190,290
-2,948
-2% -$40.3K ﹤0.01% 3197
2021
Q4 		$3.78M Buy
193,238
+12,035
+7% +$269K ﹤0.01% 3045
2021
Q3 		$4.71M Buy
181,203
+12,528
+7% +$295K ﹤0.01% 2939
2021
Q2 		$3.71M Buy
168,675
+103,218
+158% +$2.53M ﹤0.01% 3071
2021
Q1 		$1.53M Buy
65,457
+25,233
+63% +$775K ﹤0.01% 3384
2020
Q4 		$691K Buy
40,224
+21,589
+116% +$360K ﹤0.01% 3487
2020
Q3 		$303K Buy
18,635
+11,828
+174% +$143K ﹤0.01% 3592
2020
Q2 		$77K Buy
6,807
+1,109
+19% +$12.5K ﹤0.01% 3916
2020
Q1 		$57K Hold
5,698
– – ﹤0.01% 3899
2019
Q4 		$63K Hold
5,698
– – ﹤0.01% 4055
2019
Q3 		$121K Sell
5,698
-134
-2% -$2.71K ﹤0.01% 3906
2019
Q2 		$135K Sell
5,832
-3,031
-34% -$90.9K ﹤0.01% 3885
2019
Q1 		$342K Buy
8,863
+442
+5% +$19.1K ﹤0.01% 3573
2018
Q4 		$389K Buy
8,421
+1,680
+25% +$124K ﹤0.01% 3462
2018
Q3 		$920K Buy
6,741
+4,353
+182% +$748K ﹤0.01% 3255
2018
Q2 		$1.13M Buy
+2,388
New +$879K ﹤0.01% 3131

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Geode Capital Management's NMTR Position: Q3 2023 in Review

Geode Capital Management sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 108,821 shares — an estimated $73.1K sold.

Geode Capital Management first reported a position in NMTR in Q2 2018 and held it in 21 quarters. The position peaked at $4.71M in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Geode Capital Management reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Geode Capital Management sold 108,821 9 Meters Biopharma shares in Q3 2023, an estimated $73.1K.
  • Geode Capital Management first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 21 quarters.
  • Geode Capital Management's 9 Meters Biopharma position peaked at $4.71M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.